Skip to main content

Pharma News

 

Clinical courses

 

Clinical research courses

  • China NMPA approves CRISPR/Cas 9 Gene-editing Hematopoietic Stem Cell Therapy for thalassemia

    EdiGene, Inc announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the Company’s Investigational New Drug (IND) application for ET-01, an investigational CRISPR/Cas 9 gene-editing therapy for patients with transfusion dependent β-thalassemia. It marks the first gene-editing therapy and the first hematopoietic stem cell therapy IND application approval in China.

  • NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms

    “NextPharma is an established and well-respected company, with extensive experience in oral and topical finished dosage forms. As such, it is the ideal buyer given the technologies available at the Ploermel and Edinburgh sites. We are confident that the capabilities and experience at the two sites are a complementary fit with NextPharma’s portfolio and that it is ideally placed to develop both to their full potential.

  • Scientists reveal mechanism that causes irritable bowel syndrome

    KU Leuven researchers have identified the biological mechanism that explains why some people experience abdominal pain when they eat certain foods. The finding paves the way for more efficient treatment of irritable bowel syndrome and other food intolerances. The study, carried out in mice and humans, was published in Nature.

  • Webinar on Innovation & Incentivisation in MedTech Manufacturing

    Health committee, PHDCCI in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India organized the second series of Self Sufficiency in Medical Technology on “Innovation & Incentivisation of Indigenous MedTech Manufacturing” on 15th January 2021.

  • Nasal COVID-19 vaccine could soon be a reality

    In a significant development, Bharat Biotech has sought Drug Controller General India's (DCGI) approval to conduct nasal COVID-19 vaccine trials in India. The company has developed a new single-dose nasal COVID-19 vaccine in a partnership with Washington University in St Louis, USA. There are no intra-nasal COVID-19 vaccines under trial in India at the moment.

  • Target discovered that halts osteoarthritis-type knee cartilage degeneration

    There is currently no cure for osteoarthritis, but a group of scientists believe they've discovered a method through which a simple knee injection could potentially stop the disease's effects. These researchers showed that they could target a specific protein pathway in mice, put it into overdrive and halt cartilage degeneration over time.

  • 447 adverse events reported after COVID-19 vaccination

    India has vaccinated the highest number of persons on Day1 under its COVID19 vaccination program, the world’s largest such exercise. This is much higher than many other countries such as the USA, the UK and France.

    Total of 2,24,301 beneficiaries have been vaccinated till today as per the provisional report.

  • Scientist unfolds the mystery of RNA molecules folding

    A new Northwestern University-led study is unfolding the mystery of how RNA molecules fold themselves to fit inside cells and perform specific functions. The findings could potentially break down a barrier to understanding and developing treatments for RNA-related diseases, including spinal muscular atrophy and perhaps even the novel coronavirus.

  • Taurine helps to prevent Bacterial Infection

    Scientists studying the body’s natural defenses against bacterial infection have identified a nutrient taurine that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could aid efforts seeking alternatives to antibiotics.

  • World’s largest COVID19 vaccination drive rolls out at India

    Today marks a momentous day in the COVID-19 trajectory of the country as India rolls out the world’s largest COVID-19 vaccination drive today. Hon. Prime Minister will launch the nationwide vaccination exercise at 10.30 am through video conference.

    This day also sees India’s total Active Caseload (2,11,033) further slump to account for just 2% of the total positive cases. The active cases were 2,10,120 last on 29th June 2021.

    The Total Recoveries have crossed 96% of the total cases, at 96.56%.

Subscribe to Pharma News